fda banning semaglutide FDA's Removal of and the Evolving Tirzepatide Decisions: What Compounders Need to Know FDA Drug Recalls and Warnings:

Fat tissue has relatively poor blood circulation compared to muscle, which is exactly what makes it ideal for weekly injectable medications

We are talking about 28.7% average body weight reduction at the highest dose

Patients taking tirzepatide started at a dose of 2.5 mg once-weekly and then increased the dose by 2.5 mg at four-week intervals to reach their final dose

This is the most common complaint in patient surveys about GLP-1 access (Luo et al., JAMA Network Open 2024)

However, the human body is very complex, and the results of both human and animal studies have been mixed (x) (xx) (xxx) (xxxx)

This is thought to be due to the supplement improving the function of the pancreatic beta cells which in turn improves insulin sensitivity